Biocoral, Inc. (BCRA.OB)

Biocoral, Inc. is an international biotechnology company specializing in research, development and commercialization of patented high biotech technologies and biomaterials in the health care area. Through its subsidiaries, the Company researches, develops, manufactures and markets high technology biomaterials bone substitute materials made from coral, and other orthopedic, oral and maxillo-facial products, including products marketed under the trade name of BioCoral The Company owns various patents on its technologies most of which have been issued in the United States by the U.S Department of Commerce Patent and Trademark Office, and in Canada, Australia, Japan, the European community and various other countries by their official governmental patent offices. The Company has developed what management believes is the world's first fully autologous fibrin glue.

For the three months ended 31 March 2006, Biocoral, Inc's net sales fell 8% to $71K. The Company's net loss for the period decreased 7% to $886K. Revenues reflect lower sales of products in the maxillocranio facial surgery area in France and the orthopedic and neurosurgery markets. Lower loss reflects a decrease in research & development expenses due to the capitalization of certain costs incurred during the current period.